Stock Market News
Vectura slumps as Sosei 'has no attention of making an offer'
(WebFG News) - Japenese biopharmaceutical company Sosei confirmed that, contrary to recent press speculation about a possible offer for inhaler specialist Vectura, it did not intend to make a bid.
However, to ensure it wasn't completely out of the conversation for a potential acquisition of the pharmaceuticals company, Sosei left some breathing room for itself by pointing to Rule 2.8 of the UK Panel on Takeovers and Mergers' code of conduct.
Note 2 of Rule 2.8 states that Sosei, and any person acting in concert with it, reserves the right to set aside the restrictions in Rule 2.8 with the agreement of the board of Vectura, if any third party announces a firm intention to make an offer for Vectura, if Vectura announces a "whitewash" proposal, or if there has been a material change of circumstances.
In other news, Vectura's chief financial officer Andrew Derodra announced on Friday that he would be leaving respiratory medicines maker to take a new role within the industry, agreeing to take up the vacant post of finance head at diagnostic services company Unilabs.
As of 1530 BST, Vectura shares, which began to slip shortly after the announcement, were down 6.38% to 81.45p and more than 50% lower than last year's highs.
Vectura has been hit by delays to the US regulatory approval for a generic version of GlaxoSmithKline's Advair Diskus asthma drug developed in partnership with Hikma. The pair said last month they will carry out further clinical trials after the US Food & Drug Administration called for 'major' amendments to their new drug application.
However, to ensure it wasn't completely out of the conversation for a potential acquisition of the pharmaceuticals company, Sosei left some breathing room for itself by pointing to Rule 2.8 of the UK Panel on Takeovers and Mergers' code of conduct.
Note 2 of Rule 2.8 states that Sosei, and any person acting in concert with it, reserves the right to set aside the restrictions in Rule 2.8 with the agreement of the board of Vectura, if any third party announces a firm intention to make an offer for Vectura, if Vectura announces a "whitewash" proposal, or if there has been a material change of circumstances.
In other news, Vectura's chief financial officer Andrew Derodra announced on Friday that he would be leaving respiratory medicines maker to take a new role within the industry, agreeing to take up the vacant post of finance head at diagnostic services company Unilabs.
As of 1530 BST, Vectura shares, which began to slip shortly after the announcement, were down 6.38% to 81.45p and more than 50% lower than last year's highs.
Vectura has been hit by delays to the US regulatory approval for a generic version of GlaxoSmithKline's Advair Diskus asthma drug developed in partnership with Hikma. The pair said last month they will carry out further clinical trials after the US Food & Drug Administration called for 'major' amendments to their new drug application.
Related share prices |
---|
Vectura Group (VEC) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price